Dr. Mohammed Minhas Kapadia, M.D

NPI: 1760792170
Total Payments
$2,101
2023 Payments
$373.20
Companies
5
Transactions
30

Payment Breakdown by Category

Food & Beverage$2,101 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,101 30 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $1,480 21 $0 (2023)
Neurocrine Biosciences, Inc. $418.64 5 $0 (2023)
Otsuka America Pharmaceutical, Inc. $113.05 1 $0 (2019)
Indivior Inc. $49.99 1 $0 (2020)
ITI, Inc. $39.91 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $373.20 6 Neurocrine Biosciences, Inc. ($294.06)
2022 $311.84 4 Janssen Pharmaceuticals, Inc ($168.71)
2021 $412.03 6 Janssen Pharmaceuticals, Inc ($412.03)
2020 $49.99 1 Indivior Inc. ($49.99)
2019 $954.33 13 Janssen Pharmaceuticals, Inc ($841.28)

All Payment Transactions

30 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
04/27/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $57.78 General
Category: Neuroscience
04/19/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $137.54 General
Category: Neuropsychiatry
03/01/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.45 General
Category: Neuropsychiatry
03/01/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $3.24 General
Category: Neuropsychiatry
02/08/2023 Neurocrine BioSciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $138.83 General
Category: Neuropsychiatry
02/01/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $21.36 General
Category: PSYCHIATRY
10/26/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $18.55 General
Category: PSYCHIATRY
07/06/2022 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage Cash or cash equivalent $124.58 General
Category: Neuropsychiatry
06/22/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $45.91 General
Category: Neuroscience
05/13/2022 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $122.80 General
Category: Neuroscience
12/07/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $97.11 General
Category: Neuroscience
11/23/2021 Janssen Pharmaceuticals, Inc INVEGA TRINZA (Drug) Food and Beverage In-kind items and services $48.19 General
Category: Neuroscience
10/21/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $49.96 General
Category: Neuroscience
09/16/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $116.77 General
Category: Neuroscience
09/16/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $50.00 General
Category: Neuroscience
07/29/2021 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $50.00 General
Category: Neuroscience
02/11/2020 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $49.99 General
Category: BH
11/13/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $45.71 General
Category: Neuroscience
10/01/2019 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $113.05 General
Category: PSYCHIATRY
09/12/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $44.99 General
Category: Neuroscience
09/12/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $44.99 General
Category: Neuroscience
08/27/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $123.26 General
Category: Neuroscience
08/14/2019 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $48.44 General
Category: Neuroscience
07/09/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $49.99 General
Category: Neuroscience
06/27/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $119.98 General
Category: Neuroscience

About Dr. Mohammed Minhas Kapadia, M.D

Dr. Mohammed Minhas Kapadia, M.D is a Child & Adolescent Psychiatry healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1760792170.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Minhas Kapadia, M.D has received a total of $2,101 in payments from pharmaceutical and medical device companies, with $373.20 received in 2023. These payments were reported across 30 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($2,101).

Practice Information

  • Specialty Child & Adolescent Psychiatry
  • Location San Jose, CA
  • Active Since 10/19/2010
  • Last Updated 03/28/2019
  • Taxonomy Code 2084P0804X
  • Entity Type Individual
  • NPI Number 1760792170

Products in Payments

  • INVEGA SUSTENNA (Drug) $1,007
  • SPRAVATO (Drug) $425.08
  • INGREZZA (Drug) $418.64
  • ABILIFY MAINTENA (Drug) $113.05
  • PERSERIS (Drug) $49.99
  • INVEGA TRINZA (Drug) $48.19
  • CAPLYTA (Drug) $39.91

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Child & Adolescent Psychiatry Doctors in San Jose